OSIR - Osiris Therapeutics, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD

Osiris Therapeutics, Inc.

7015 Albert Einstein Drive
Columbia, MD 21046
United States
443-545-1800
http://www.osiristx.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees337

Key Executives

NameTitlePayExercisedYear Born
Mr. Philip R. Jacoby Jr.Interim Principal Accounting Officer244.33k128.83k1953
Mr. Jason KeeferInterim CEO & PresN/AN/A1972
Ms. Linda L. ChangChief Financial OfficerN/AN/A1966
Dr. Alla N. Danilkovitch Ph.D.Chief Scientific OfficerN/AN/A1964
Mr. Richard SkowGen. Counsel & Corp. Sec.N/AN/AN/A
Amounts are as of December 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix and Stravix for treating chronic wounds of diabetic foot ulcers, venous leg ulcers, pressure ulcers, arterial ulcers, and severe burns, as well as surgical and trauma wounds; BIO4 for bone repair and regeneration in spine, trauma, extremity, cranial, and foot and ankle surgeries; and Cartiform for treating articular cartilage lesions in the knee and other joints. The company also develops and markets Menvivo for the repair of meniscus; and TruSkin for treating chronic wounds. It markets and distributes its products directly to physicians, hospitals, and other healthcare providers, as well as through agents and distributors. Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.

Corporate Governance

Osiris Therapeutics, Inc.’s ISS Governance QualityScore as of April 1, 2018 is 7. The pillar scores are Audit: 5; Board: 8; Shareholder Rights: 3; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.